Nanocarrier-enhanced intracellular delivery of benznidazole for treatment of Trypanosoma cruzi infection is a research paper published in JCI Insight (2021). On theSindex it has a DataRank of 0.385. It has been cited 12 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.385
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NHLBI NIH HHS
Grant: DP2 HL132390
NIAID NIH HHS
Grant: R21 AI144529
National Institutes of Health
Grant: 7R21AI144529-02
Development and characterization of a nanocarrier for enhanced delivery of benznidazole during acute and chronic T. cruzi infection
National Institutes of Health
Grant: 1DP2HL132390-01
Development of combination immunotherapies for atherosclerotic inflammation
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals